Susanne Staer

TIAP Launches Next Generation Program to Support Early-Stage Drug Development LAB150-NextGen to offer up to $1.6M USD per project to advance new drug candidatesMay 20, 2025Building on the success of…

TIAP Voices: The Venture Building Journey and the Importance of Balanced Investor Engagement by: Mobeen Lalani, TIAP Senior Analyst, Technology and Venture Development In today’s ever-evolving health innovation and business…

Government of Canada invests in southern Ontario’s life sciences sector From: Federal Economic Development Agency for Southern Ontario News release Six life sciences organizations expand manufacturing capabilities and commercialize innovations February…

Grey Matter Neurosciences Secures License for World-Leading Focused Ultrasound Technology from Sunnybrook Research Institute, Announces $14 Million Financing to Advance Treatment for Alzheimer's Disease News provided by Grey Matter Neurosciences …

Myant Accelerates Precision Healthcare with Acquisition of Bitnobi Inc. USA - English  News provided by Myant Corp.  Jan 16, 2025, 10:55 ET TORONTO, Jan. 16, 2025 /PRNewswire/ -- Myant, a global leader…

TIAP FEATURES: Critical Technologies From Sunnybrook Research Institute Powering Advances In Therapeutic Ultrasound Catheters   TIAP’s Critical Technologies Program continues to gather steam with the latest initiative to receive support…

TIAP Voices: From Insight to Innovation — Ensuring Your Discovery Process Includes Discovering Your Customer By: Mobeen Lalani, TIAP Senior Analyst, Technology and Venture Development In the dynamic world of…

Radiant Bio Closes $35 Million Series A Financing to Advance Therapeutic Pipeline with Its Proprietary Multabody™ Platform Funding co-led by the Bill & Melinda Gates Foundation and Amplitude Ventures to…

HDAX Therapeutics Announces First Closing of Oversubscribed US $3.2 (CA $4.3) Million Seed Financing TORONTO--HDAX Therapeutics (“HDAX”), a biotechnology company pioneering a novel approach to targeting HDAC6 for the discovery and…

TIAP Announces First Project to Receive Support Under Newly Launched Critical Technologies Program ScarDx Brings Cutting-Edge Innovation to Fibrosis Detection April 29, 2024 – Toronto, Ontario – Toronto Innovation Acceleration…